TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
-3.25%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.29B
AUM Growth
-$158M
Cap. Flow
-$50.3M
Cap. Flow %
-2.19%
Top 10 Hldgs %
41.8%
Holding
210
New
13
Increased
53
Reduced
56
Closed
18

Top Buys

1
MRK icon
Merck
MRK
$16.6M
2
ILMN icon
Illumina
ILMN
$13M
3
HUM icon
Humana
HUM
$9.23M
4
BIIB icon
Biogen
BIIB
$7.74M
5
ALXN
Alexion Pharmaceuticals Inc
ALXN
$5.28M

Top Sells

1
AMGN icon
Amgen
AMGN
$18.8M
2
ABT icon
Abbott
ABT
$15.2M
3
ARRY
Array Biopharma Inc
ARRY
$15M
4
TMO icon
Thermo Fisher Scientific
TMO
$13.7M
5
LLY icon
Eli Lilly
LLY
$10.8M

Sector Composition

1 Healthcare 94.94%
2 Real Estate 3.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BSX icon
26
Boston Scientific
BSX
$159B
$23M 1%
564,950
-67,300
-11% -$2.74M
DHR icon
27
Danaher
DHR
$143B
$22M 0.96%
171,880
-7,394
-4% -$947K
NVS icon
28
Novartis
NVS
$251B
$21.7M 0.95%
249,447
-27,600
-10% -$2.4M
HUM icon
29
Humana
HUM
$37B
$21.5M 0.94%
84,234
+36,112
+75% +$9.23M
VTRS icon
30
Viatris
VTRS
$12.2B
$20.5M 0.9%
1,038,554
+95,402
+10% +$1.89M
CI icon
31
Cigna
CI
$81.5B
$19M 0.83%
124,995
+8,239
+7% +$1.25M
NBIX icon
32
Neurocrine Biosciences
NBIX
$14.3B
$18.6M 0.81%
206,822
-256
-0.1% -$23.1K
LLY icon
33
Eli Lilly
LLY
$652B
$17.6M 0.77%
156,958
-96,241
-38% -$10.8M
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.1B
$16.6M 0.72%
245,763
– –
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
$15.2M 0.66%
153,003
– –
BDX icon
36
Becton Dickinson
BDX
$55.1B
$14.8M 0.64%
59,899
– –
MCK icon
37
McKesson
MCK
$85.5B
$14.7M 0.64%
107,266
+11,575
+12% +$1.58M
BAX icon
38
Baxter International
BAX
$12.5B
$14.4M 0.63%
164,958
-11,740
-7% -$1.03M
COR icon
39
Cencora
COR
$56.7B
$14.4M 0.63%
174,338
+34,065
+24% +$2.8M
EW icon
40
Edwards Lifesciences
EW
$47.5B
$14.3M 0.63%
195,720
-13,587
-6% -$996K
WELL icon
41
Welltower
WELL
$112B
$13.8M 0.6%
152,322
– –
IDXX icon
42
Idexx Laboratories
IDXX
$51.4B
$13.5M 0.59%
49,776
-11,978
-19% -$3.26M
ALNY icon
43
Alnylam Pharmaceuticals
ALNY
$59.4B
$13.4M 0.58%
166,275
+4,903
+3% +$394K
BLUE
44
DELISTED
bluebird bio
BLUE
$12.9M 0.56%
10,830
+2,962
+38% +$3.52M
NVO icon
45
Novo Nordisk
NVO
$245B
$12.5M 0.54%
482,000
– –
AZN icon
46
AstraZeneca
AZN
$253B
$12.3M 0.54%
276,098
-58,900
-18% -$2.63M
SAGE
47
DELISTED
Sage Therapeutics
SAGE
$12.2M 0.53%
86,780
+2,635
+3% +$370K
HCA icon
48
HCA Healthcare
HCA
$98.5B
$11.8M 0.52%
98,393
+8,824
+10% +$1.06M
ONC
49
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
$11.5M 0.5%
94,289
-600
-0.6% -$73.5K
OHI icon
50
Omega Healthcare
OHI
$12.7B
$11.4M 0.5%
272,766
– –
1
2
3 4 5